Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Newtopia Inc. (NEWUF)

0.0005
0.0000
(0.00%)
As of May 1 at 4:00:00 PM EDT. Market Open.
Loading Chart for NEWUF
  • Previous Close 0.0005
  • Open 0.0005
  • Bid 0.0005 x --
  • Ask 0.0188 x --
  • Day's Range 0.0005 - 0.0005
  • 52 Week Range 0.0003 - 0.0669
  • Volume 429,555
  • Avg. Volume 8,648
  • Market Cap (intraday) 628,130
  • Beta (5Y Monthly) -1.47
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date May 21, 2025 - May 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.

www.newtopia.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NEWUF

View More

Performance Overview: NEWUF

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NEWUF
64.29%
S&P/TSX Composite index (^GSPTSE)
1.34%

1-Year Return

NEWUF
99.25%
S&P/TSX Composite index (^GSPTSE)
14.32%

3-Year Return

NEWUF
99.61%
S&P/TSX Composite index (^GSPTSE)
20.57%

5-Year Return

NEWUF
99.91%
S&P/TSX Composite index (^GSPTSE)
70.65%

Compare To: NEWUF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NEWUF

View More

Valuation Measures

Annual
As of 5/1/2025
  • Market Cap

    626.46k

  • Enterprise Value

    8.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.74

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -108.09%

  • Return on Assets (ttm)

    -60.32%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.71M

  • Net Income Avi to Common (ttm)

    -7.26M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.2k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -332.15k

Research Analysis: NEWUF

View More

Company Insights: NEWUF

Research Reports: NEWUF

View More

People Also Watch